Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled

Go back to Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled
(NASDAQ: CMND) Delayed: 0.78 -0.01 (1.27%)
Previous Close $0.79    52 Week High
Open $0.78    52 Week Low
Day High $0.79    P/E N/A 
Day Low $0.77    EPS
Volume 76,260